Sign Up to like & get
recommendations!
0
Published in 2018 at "Urolithiasis"
DOI: 10.1007/s00240-018-1081-7
Abstract: Ureteric stents have become an indispensable tool in the armamentarium of every urologist. However, they carry their own morbidity resulting mostly from infectious or abacterial fouling and biofilm formation, and/or urothelial hyperplastic reaction. All of…
read more here.
Keywords:
coated stents;
proliferation ureteral;
paclitaxel coated;
hyperplastic proliferation ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Cardiovascular and Interventional Radiology"
DOI: 10.1007/s00270-020-02602-6
Abstract: Recently, two meta-analyses concluded that there appears to be an increased risk of long-term mortality of paclitaxel-coated balloons and stents in the superficial femoral and popliteal artery, and paclitaxel-coated balloons below the knee. In this…
read more here.
Keywords:
trial;
padi trial;
mortality;
paclitaxel coated ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Clinical Research in Cardiology"
DOI: 10.1007/s00392-017-1126-x
Abstract: AimWe investigated the efficacy and safety of using paclitaxel-coated balloon (PCB) to treat small vessel disease.Methods and resultsIn this multicenter, prospective, randomized controlled trial, one-hundred and thirty-five patients with native coronary lesions in small vessels…
read more here.
Keywords:
group;
paclitaxel coated;
small vessel;
pcb ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2021 at "Current Cardiology Reports"
DOI: 10.1007/s11886-021-01477-4
Abstract: Peripheral artery disease (PAD) is a common, debilitating disease that impacts 8.5 million Americans and carries a poor prognosis. The most common manifestation of lower extremity PAD is claudication—a condition which significantly reduces quality of…
read more here.
Keywords:
coated devices;
safety;
mortality;
paclitaxel coated ... See more keywords
Photo by nci from unsplash
Sign Up to like & get
recommendations!
0
Published in 2020 at "Annals of vascular surgery"
DOI: 10.1016/j.avsg.2020.06.010
Abstract: Drug-coated balloons (DCB) are used widely as a form of endovascular treatment for peripheral arterial disease, to improve patency by reducing neointimal hyperplasia and re-stenosis. We present a rare case of acute coronary syndrome secondary…
read more here.
Keywords:
superficial femoral;
paclitaxel coated;
syndrome following;
femoral artery ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2019 at "EClinicalMedicine"
DOI: 10.1016/j.eclinm.2019.09.004
Abstract: Background Paclitaxel-coated balloons (DCB) are suitable to reduce the risk of restenosis after angioplasty of atherosclerotic femoropopliteal lesions. However, numerous types of DCBs are distinguished by drug density and coating. Conflicting evidence exists about the…
read more here.
Keywords:
balloon angioplasty;
risk;
treatment femoropopliteal;
treatment ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2019.03.166
Abstract: Arteriovenous graft (AVG) dysfunction is mainly caused by neointimal hyperplasia. Endovascular intervention can salvage the stenosis. But the long-term patent rate doesn’t improve due to repeated restenosis. Paclitaxel-coated balloon (PCB) is used to reduce neointimal…
read more here.
Keywords:
arteriovenous graft;
paclitaxel coated;
coated balloon;
stenosis ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Vascular Surgery"
DOI: 10.1016/j.jvs.2020.04.525
Abstract: Abstract Objective The comparison between paclitaxel-coated balloon (PCB) and plain old balloon angioplasty (POBA) for hemodialysis (HD) access stenosis/occlusion has not been well investigated. The objectives of this systematic review and meta-analysis were to compare…
read more here.
Keywords:
meta analysis;
access;
patency;
paclitaxel coated ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2018 at "Coronary Artery Disease"
DOI: 10.1097/mca.0000000000000617
Abstract: Background Paclitaxel-coated balloon (PCB) coronary angioplasty is an alternative treatment for de-novo coronary lesions in small vessels. This study with the new Essential PCB aimed to evaluate early and mid-term clinical outcomes following angioplasty with…
read more here.
Keywords:
treating novo;
small vessels;
target;
paclitaxel coated ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Coronary Artery Disease"
DOI: 10.1097/mca.0000000000000620
Abstract: Objectives Periprocedural myocardial infarction (PMI) is reported to be associated with adverse long-term clinical outcomes. This study compared the rates of PMI following treatment of de novo coronary lesions using either a paclitaxel-coated balloon (PCB)…
read more here.
Keywords:
periprocedural myocardial;
myocardial infarction;
generation;
paclitaxel coated ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2022 at "Circulation: Cardiovascular Interventions"
DOI: 10.1161/circinterventions.122.012305
Abstract: Background: Paclitaxel-coated balloons (PCBs) are a preferred treatment option for coronary in-stent restenosis. To date, data from randomized trials of alternative drug coatings are lacking. The aim of the randomized Malaysian and German-Swiss randomized trials…
read more here.
Keywords:
coated balloons;
restenosis;
coronary stent;
randomized trials ... See more keywords